IP Library Patent Application 12781628
Patent Application
App. No. 12/781,628

SUBLINGUAL DEXMEDITOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/781,628
Abstract

Analgesic sublingual formulations of dexmedetomidine and methods of use thereof are provided for use in the prevention, treatment and management of pain and other conditions.

Claims (6)

1 . A method of treating or preventing pain comprising

applying to the oral mucosa of a human a pharmaceutical composition comprising a dosage of dexmedetomidine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable liquid vehicle,

wherein said dexmedetomidine or pharmaceutically acceptable salt thereof is absorbed through said oral mucosa and produces analgesia without sedation.

2 . The method according to claim 1 , wherein said dosage of dexmedetomidine or pharmaceutically acceptable salt thereof is between about 0.05 μg/kg and about 1.50 μg/kg.

3 . The method according to claim 1 , wherein the plasma C max of dexmedetomidine upon transmucosal absorption into the systemic circulatory system of said human is less than about 0.30 ng/mL.

4 . The method according to claim 1 , wherein said applying step comprises sublingually or buccally applying said pharmaceutical composition to the oral cavity of said human.

Assignments (7)
SECURITY INTEREST Recorded Jun 10, 2020
From: BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED; BAUDAX BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052891/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2020
From: RECRO PHARMA, INC.
To: BAUDAX BIO, INC.
Reel/Frame 051671/0536 →
RELEASE OF SECURITY INTEREST Recorded Nov 17, 2017
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: RECRO PHARMA, INC.
Reel/Frame 044481/0907 →
SECURITY INTEREST Recorded Apr 14, 2015
From: RECRO PHARMA, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0197 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR AND ASSIGNEE INFORMATION PREVIOUSLY RECORDED ON REEL 031571 FRAME 0676. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ASSIGNOR IS MALVERN CONSULTING GROUP, INC. AND THE CORRECT ASSIGNEE IS RECRO PHARMA, INC.. Recorded Nov 12, 2013
From: MALVERN CONSULTING GROUP, INC.
To: RECRO PHARMA, INC.
Reel/Frame 031626/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2013
From: RECRO PHARMA, INC.
To: MALVERN CONSULTING GROUP, INC.
Reel/Frame 031571/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2010
From: HENWOOD, GERALDINE A.; MACK, RANDALL J.; SHARR, CHRISTOPHER T.; KOLENG, JOHN J.
To: RECRO PHARMA, INC.
Reel/Frame 025546/0487 →